Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Biome Australia Ltd ( (AU:BIO) ) has provided an update.
Biome Australia Limited has announced an investor webinar scheduled for June 5th, where the company’s Managing Director, Blair Vega Norfolk, will introduce the new Chair, Geoff Sam OAM, and provide a general business update. This event reflects Biome’s ongoing commitment to engaging with investors and stakeholders, potentially impacting its market positioning by showcasing leadership changes and business strategies.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.85 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited is a company that develops, licenses, commercializes, and markets innovative, evidence-based live biotherapeutics (probiotics) and complementary medicines. These products are supported by clinical research and aim to improve health outcomes and quality of life. Incorporated in Australia in 2018, Biome distributes its products locally and internationally, partnering with leading organizations in microbiome research and development to produce unique probiotic products with innovative delivery technologies.
Average Trading Volume: 240,648
Technical Sentiment Signal: Sell
See more data about BIO stock on TipRanks’ Stock Analysis page.